Like I said, there are requests for additional informstion and approvals. There are no "rejections". The clinical oversight committee determined "insufficient clinical benefit has been demonstrated to recommend approval".
Without any uncertainty, the request is for a powered randomised controlled trial.
- Forums
- ASX - By Stock
- Ann: CE Marking Update
OSL
oncosil medical ltd
Add to My Watchlist
4.42%
!
$1.08

Like I said, there are requests for additional informstion and...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$1.08 |
Change
-0.050(4.42%) |
Mkt cap ! $20.33M |
Open | High | Low | Value | Volume |
$1.15 | $1.15 | $1.08 | $45.62K | 40.76K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 718 | $1.08 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.10 | 2361 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 718 | 1.080 |
2 | 6494 | 1.075 |
3 | 26387 | 1.060 |
1 | 961 | 1.040 |
1 | 2970 | 1.010 |
Price($) | Vol. | No. |
---|---|---|
1.110 | 9892 | 1 |
1.120 | 6671 | 2 |
1.140 | 5000 | 1 |
1.145 | 5000 | 1 |
1.150 | 6938 | 1 |
Last trade - 16.10pm 30/07/2025 (20 minute delay) ? |
Featured News
OSL (ASX) Chart |